Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06309693 · ClinicalTrials.gov registry record · NA
Postoperative Pain Management Following Robotic Assisted Sacrocolpopexy
A NA study, sponsored by University of Alabama at Birmingham.
- Completed
- Registry status
- NA
- Development phase
- 70
- Enrollment target
NCT06309693 is a NA study that has completed, run by University of Alabama at Birmingham. The registered enrollment target is 70 participants.
The verdict
NCT06309693, a NA study, has completed, sponsored by University of Alabama at Birmingham.
- COMPLETED
- Registry status
- NA
- Development phase
- 70 participants
- Enrollment target
Study Summary
In the effort to reduce postoperative opioid use, there has been increasing interest in developing multimodal pain regimens to better manage postoperative pain while minimizing opioid use and their subsequent side effects that can be detrimental to the healing process. Standard of care approaches to better manage postoperative pain include the Enhanced Recovery After Surgery (ERAS) protocol and the use of peripheral and truncal nerve blocks. Truncal nerve blocks are widely used as an additional modality to provide longer lasting postoperative analgesia and have been adopted as part of the standard of care. The goal of this clinical trial is to compare the effects of ERAS alone versus the quadratus lumborum (QL) nerve block on the postoperative pain experience for women with pelvic organ prolapse undergoing robotic assisted sacrocolpopexy. Subjects will be randomized to the ERAS protocol or the QL block. The main questions the study aims to answer are: 1) does the QL block decrease patient reported pain scores postoperatively; and 2) does the QL block decrease the amount of opioid pain medications in the immediate postoperative period? The primary outcome measure will be median patient reported pain score in the post-anesthesia care unit (PACU) following surgery.
Interventions
- PROCEDURE Quadratus Lumborum (QL) Block
- PROCEDURE Enhanced Recovery After Surgical (ERAS) Protocol
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 70 participants |
| Start Date | 2025-01-22 |
| Est. Completion | 2026-01-09 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT06309693
The ClinicalTrials.gov registry entry for NCT06309693 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 70 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Alabama at Birmingham, which has 1,160 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Quadratus Lumborum (QL) Block is the first listed.
NCT06309693 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT06309693 about?
NCT06309693 is a clinical study titled "Postoperative Pain Management Following Robotic Assisted Sacrocolpopexy". In the effort to reduce postoperative opioid use, there has been increasing interest in developing multimodal pain regimens to better manage postoperative pain while minimizing opioid use and their subsequent side effects that can be detrimental to the healing process. Standard of care approaches to...
What is the current status of trial NCT06309693?
This trial is currently completed. It is a NA study. The enrollment target is 70 participants. The study started on 2025-01-22. Estimated completion is 2026-01-09.
What interventions are being tested in trial NCT06309693?
The interventions under investigation include: Quadratus Lumborum (QL) Block (PROCEDURE), Enhanced Recovery After Surgical (ERAS) Protocol (PROCEDURE).
Who is sponsoring clinical trial NCT06309693?
This trial is sponsored by University of Alabama at Birmingham, which has 1,160 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.